Newsletter | March 3, 2025

03.03.25 -- Challenges And Opportunities Of Outsourcing Biopharma Development

SPONSOR

Join Cell & Gene Live for an exclusive look at cutting-edge manufacturing technologies revolutionizing cell therapy production. Our expert panel will explore organoids, 3D cultures, automation, and scalable solutions to streamline processes and enhance efficiency. Gain insights into the latest innovations driving the future of cell therapy. Registration is free thanks to the support of CPC and MaxCyte.

FOCUS ON OUTSOURCING

Challenges And Opportunities Of Outsourcing Biopharma Development

Oversight, knowledge management, and operational/compliance risk make up the three key challenge classifications to consider when approaching a new outsourcing agreement.

Integrating Analytical Method Development And Quality Control

As cell and gene therapies continue to advance, a well-integrated analytical framework will be critical for accelerating development timelines and optimizing regulatory submissions.

Identifying The Right Analytical Strategy For AAV Production

AAV has become an increasingly popular vector for gene therapy applications, yet ongoing challenges related to process and analytical development often require significant expertise to navigate.

The High Cost Of Going Cheap

Developers often aim to cut expenses during development. Discover the long-term outcomes of cost-effective measures like using RUO leukopaks compared to investing in high-quality GMP-grade vectors.

Exploring The Cost Considerations Of Immune Cell Therapies

Immune cell therapies have incredible potential for cancer treatment, and making them more cost effective is a critical consideration for improving patient access and outcomes.

Combining An MVA Technology Platform With Innovative Analytical Methods

Learn how an innovative process development platform for MVA is impacting vaccine manufacturing and supporting the drug life cycle through clinical trials and commercialization.

Sustainable Approaches To Oligonucleotide Manufacturing

An industry expert shares about sustainable Oligo manufacturing approaches that can save time, cost, and resources – while improving purity, quality, and scalability of these promising therapeutics.

New 30-Color Spectral Flow Cytometry Panel For T Cell Therapy

Explore how Labcorp's 30-color immunophenotyping panel, powered by Cytek Aurora™ Spectral Flow Cytometry, can enhance your T cell therapy studies across in vitro, preclinical, and clinical stages.

OUTSOURCING SOLUTIONS

Advanced Medicine Partners Capacity Update October 2024 - Advanced Medicine Partners

Take The Next Step In Your mRNA Product Journey - Novartis Contract Manufacturing

WuXi Advanced Therapies Philadelphia Campus Overview - WuXi Advanced Therapies

Analytical Testing Capabilities - Comprehensive Cell Solutions, A Business Unit of NYBC Enterprises

Connect With Cell & Gene: